The group of Kristina Ganzinger carries out fundamental research that is of potential interest for new or improved medicines. But, how to take knowledge from our labs to the marketplace where patients can benefit from it? The group is now taking important steps to make this possible. Kristina announced that - together with partner 1NA - the group is officially joining the Biotech Booster program that supports commercialization of biotechnology findings. The research project introduced in the program is entitled NanoLoom. It aims to unlock the potential of single-molecule techniques for drug development. This is done by combining the DNA curtain technology of partner company 1NA with AMOLF DNA-PAINT labeling techniques. The collaborating partners will conduct proof-of-concept studies combining the two techniques. This will enable them to do long-time observation of DNA-protein interactions across thousands of DNA molecules, providing a new setting to assess efficacy and mechanisms of action for new or existing drugs on DNA binding molecules.
We're thrilled to announce that we will now officially join the Biotech Booster program! With the funding and support from entrepreneurs, experts, knowledge institutes and others from the biotech sector, we’re ready to take the next steps towards validating and developing our findings together with 1NA and leveraging biotechnology to achieve societal impact! Follow us and Biotech Booster to stay up-to-date on our progress. AMOLF, Oncode Institute, Nationaal Groeifonds, Willem-Jan Keune